I’m not aware of any data outside of the preclinical data they referred to for efti in infectious disease. With infectious disease patents in Japan and Europe, I guess it’s only because of resources efti has not been tried in infectious disease. The hypothesis for Covid-19 is worth trying, especially with all the noodles being thrown at the wall by other companies.. AMRN is trying fish oil for the cardiovascular effects of Covid-19. Come on, let’s see is APC activation shortens infection, like soon.
A major investor looks at the odds for IMM !, page-23
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 33.0¢ | $1.220M | 3.642M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 57289 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 52306 | 3 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |